Skip to content

MERCK

Active
Public limited company·Groothandel in farmaceutische en medische artikelen· 74 yrs active
Ildefonse Vandammestraat 5/7B ·1560 Hoeilaart, Belgium
KBO/BCE: BE 0403.047.965
Watch Print / PDF
Age74 yrs
Board3
Connections1
Real estate2 parcels · 3,772 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MERCK is 0.4% (very low). The company has been active since 1951 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Trust signals

2 signals
Long-established
Founded in 1951, 75 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.4% Very low
0%0,5%1,5%4%10%≥25%
Long track record −Multiple establishment units +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 27-06-2025 2025-00201441
31-12-2023 volledig 24-06-2024 2024-00179094
31-12-2022 volledig 19-06-2023 2023-00140548
31-12-2021 volledig 11-07-2022 2022-20185218
31-12-2020 volledig 28-07-2021 2021-40900154
31-12-2019 volledig 03-07-2020 2020-25100533
31-12-2018 volledig 27-06-2019 2019-23800522
31-12-2017 volledig 19-06-2018 2018-19500081
31-12-2016 volledig 05-07-2017 2017-28500313
31-12-2015 volledig 24-06-2016 2016-22600380

Directors

Directors & mandates

20 directors
Current directors & mandates
  • Susan King-Barnardo
    Director
    State Gazette act 26070873 (03-06-2026)
    Current
    01-05-2026 → present
    2 events
    • 01-05-2026 Appointed· Director
    • 01-05-2026 Appointed· Managing director
  • Spasena Yotova
    Director
    State Gazette act 25069885 (03-06-2025)
    Current
    01-04-2025 → present
  • Benoit Christophe Elichabe
    Director
    State Gazette act 21062445 (27-05-2021)
    Current
    01-05-2021 → present
Historic, not recently confirmed (5)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Spasena Ivanova Yotova
    Director
    State Gazette act 19066227 (16-05-2019)
    Not recently confirmed
    last confirmed in an act from 2019
  • Ronald Rahi
    Director
    State Gazette act 17068935 (16-05-2017)
    Not recently confirmed
    last confirmed in an act from 2017
  • Laurent HENAUX
    Director
    State Gazette act 10134177 (14-09-2010)
    Not recently confirmed
    last confirmed in an act from 2010
  • Guy Tonon
    Director
    State Gazette act 08064038 (28-04-2008)
    Not recently confirmed
    last confirmed in an act from 2008
  • Olaf Klinger
    Director
    State Gazette act 08064038 (28-04-2008)
    Not recently confirmed
    last confirmed in an act from 2008
Former directors (12)
  • Benoit Elichabe
    Managing director
    State Gazette act 21062445 (27-05-2021)
    Former
    01-05-2021 → 01-05-2026
    2 events
    • 01-05-2026 Resigned· Director
    • 01-05-2021 Appointed· Managing director
  • Christian Duerr
    Director
    State Gazette act 21091232 (30-07-2021)
    Former
    26-07-2021 → 31-12-2021
    2 events
    • 31-12-2021 Resigned· Director
    • 26-07-2021 Appointed· Director
  • Christos Andriopoulos
    Managing director
    State Gazette act 18185748 (31-12-2018)
    Former
    01-12-2018 → 01-05-2021
    3 events
    • 01-05-2021 Resigned· Director
    • 04-12-2018 Appointed· Managing director
    • 01-12-2018 Appointed· Director
  • Ariane Misonne
    Managing director
    State Gazette act 15162605 (20-11-2015)
    Former
    01-07-2015 → 01-12-2018
    4 events
    • 01-12-2018 Resigned· Managing director
    • 01-12-2018 Resigned· Director
    • 01-10-2015 Appointed· Managing director
    • 01-07-2015 Appointed· Director
  • Jean-Pierre Darriot
    Director
    State Gazette act 16040280 (21-03-2016)
    Former
    01-02-2016 → 27-04-2017
    2 events
    • 27-04-2017 Resigned· Director
    • 01-02-2016 Appointed· Director
  • Marie-Andrée Gamache
    Director
    State Gazette act 15162605 (20-11-2015)
    Former
    01-10-2015 → 27-04-2017
    2 events
    • 27-04-2017 Resigned· Director
    • 01-10-2015 Appointed· Director
  • Björn Hermes
    Director
    State Gazette act 16001068 (05-01-2016)
    Former
    - → 17-12-2015
  • Uloff Muenster
    Director
    State Gazette act 15131803 (17-09-2015)
    Former
    - → 30-06-2015
  • Brigitte DEMUNTER
    Director
    State Gazette act 08064038 (28-04-2008)
    Former
    28-04-2008 → 30-09-2009
    2 events
    • 30-09-2009 Resigned· Director
    • 28-04-2008 Appointed· Director
  • JACOB Vincent
    Director
    State Gazette act 08064038 (28-04-2008)
    Former
    - → 28-04-2008
  • Pierre Lambert
    Director
    State Gazette act 08064038 (28-04-2008)
    Former
    - → 28-04-2008
  • Stefan Rupp
    Director
    State Gazette act 08064038 (28-04-2008)
    Former
    - → 28-04-2008
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Statutory auditor

3 auditors
Statutory auditor IRE/IBR number Tenure
Deloitte Bedrijfsrevisoren/Réviseurs d'EntreprisesCurrent
Statutory auditor · represented by Gert Vanhees
 - 16-06-2023 → present
KPMG Bedrijfsrevisoren Burgerlijke vennootschap onder de vorm van coöperatieve vennootschap met beperkte aansprakelijkheid
Statutory auditor · represented by Olivier Declercq
succeeded by KPMG Bedrijfsrevisoren CVBA in 2020
 - 01-07-2017 → 19-06-2020
KPMG Bedrijfsrevisoren CVBA
Statutory auditor · represented by Olivier Declercq
succeeded by Deloitte Bedrijfsrevisoren/Réviseurs d'Entreprises in 2023
 - 19-06-2020 → 16-06-2023
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Groothandel in farmaceutische en medische artikelen(46460)
Legal form Public limited company(014)
Incorporation23-08-1951
StatusActive
Postal code1560

Structure & network

Connections & network

1 connected company
Network connections
Merck Chemicals NV/SA
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Establishment units

2 locations
Merck Serono
Ildefonse Vandammestraat 5/7, 1560 Hoeilaartde vervaardiging van salicylzuur en o-acetylsalicylzuur
since 19512.005.628.418
Merck N.V.-S.A
Belliardstraat 15/17, 1040 EtterbeekGroothandel in farmaceutische en medische artikelen
since 20192.288.072.028
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area3,772 m²
Buildings2
Building footprint1,387 m²
Volume (LiDAR)21,794 m³
Tallest building35.6 m · ±11 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
23033C0080/00H016 Flanders 3,343 m² 1 · 1,079 m² 17.1 m · 4 fl.
21805E0377/00D000 Brussels 429 m² 1 · 308 m² 35.6 m · 11 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

33 acts
Company purpose
Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.
Per act of 22-07-2020
All acts · 33 updated 2 months ago
2026
03-06-2026 2 directors appointed, 1 resigning Director changes
  • Susan King-Barnardo, Bestuurder
  • Susan King-Barnardo, Gedelegeerd bestuurder
  • Benoit Elichabe, Bestuurder
Summary: v3.2
2025
06-06-2025 Change in the board of directors Director changes
Summary: v3.2
03-06-2025 Spasena Yotova reappointed as director Director changes
  • Spasena Yotova, Bestuurder
Summary: v3.2
2024
17-01-2024 Articles of association amended Statutes amendment
Summary: v3.2
2023
27-10-2023 1 director appointed, 1 resigning Director changes
  • Gert Vanhees, Commissaris
  • KPMG Bedrijfsrevisoren, Commissaris
Summary: v3.2
2022
03-10-2022 Change in the board of directors Director changes
Summary: v3.2
08-03-2022 Christian Duerr resigns as director Director changes
  • Christian Duerr, Bestuurder
Summary: v3.2
2021
30-07-2021 Christian Duerr appointed as director Director changes
  • Christian Duerr, Bestuurder
Summary: v3.2
27-05-2021 2 directors appointed, 1 resigning Director changes
  • Benoit Christophe Elichabe, Bestuurder
  • Benoit Elichabe, Gedelegeerd bestuurder
  • Christos Andriopoulos, Bestuurder
Summary: v3.2
30-04-2021 General meeting · Officer appointment · Officer reappointment · Officer resignation Open-capture extraction
  • Publication: 2021-04-23 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Filing: 2021-04-23 · Algemene Vereniging van de Geneesmiddelenindustrie
  • General meeting: 2021-03-17 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Officer appointment: role: bestuurder, start_date: 2021-03-17 · Takeda Belgium N.V.
  • Officer reappointment: role: bestuurder, start_date: 2021-03-17 · AbbVie N.V.
  • Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Amgen N.V.
  • Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Eli Lilly Benelux N.V.
  • Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Pfizer N.V.
  • Officer resignation: role: bestuurder, end_date: 2021-03-17 · Merck N.V.
  • Permanent representative · Laurerit Henaux
  • Officer appointment: role: CEO, belast met het dagelijks bestuur · Caroline Ven
Summary: General meeting · Officer appointment · Officer reappointment · Officer resignation
30-04-2021 General meeting · Officer appointment · Officer reappointment · Officer resignation Open-capture extraction
  • Publication: 2021-01-01 · Association Générale de l'Industrie du Médicament
  • Filing: 2021-04-23 · Association Générale de l'Industrie du Médicament
  • General meeting: 2021-03-17 · Association Générale de l'Industrie du Médicament
  • Officer appointment: role: administrateur, start_date: 2021-03-17 · Takeda Belgium S.A.
  • Officer reappointment: role: administrateur, start_date: 2021-03-17 · AbbVie S.A.
  • Officer reappointment: role: administrateur, start_date: 2021-03-17 · Amgen S.A.
  • Officer reappointment: role: administrateur, start_date: 2021-03-17 · Eli Lilly Benelux S.A.
  • Officer reappointment: role: administrateur, start_date: 2021-03-17 · Pfizer S.A.
  • Officer resignation: date: 2021-03-17, role: administrateur · Merck S.A.
  • Permanent representative · Laurent Henaux
Summary: General meeting · Officer appointment · Officer reappointment · Officer resignation
24-02-2021 Change in the board of directors Director changes
Summary: v3.2
2020
15-10-2020 Olivier Declercq reappointed as statutory auditor Director changes
  • Olivier Declercq, Commissaris
Summary: v3.2
09-09-2020 Change in the board of directors Director changes
Summary: v3.2
22-07-2020 Act object · Board meeting · General meeting · Officer resignation Open-capture extraction
  • Act object: Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
  • Publication: 2020-07-22 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Filing: 2020-07-13 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Board meeting: 2020-02-19 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Board meeting: 2020-06-24 · Algemene Vereniging van de Geneesmiddelenindustrie
  • General meeting: 2020-05-13 · Algemene Vereniging van de Geneesmiddelenindustrie
  • Officer resignation: role: algemeen directeur, end_date: 2020-07-01 · Catherine Auguste J. Rutten
  • Officer appointment: role: algemeen directeur ad interim, start_date: 2020-07-01 · Ann Maria Marcel Ludo Adriaensen
  • Officer appointment: role: Voorzitter Raad van Bestuur · Pfizer
  • Permanent representative · Karel Van De Sompel
  • Officer appointment: role: Ondervoorzitter Raad van Bestuur · Eli Lilly Benelux
  • Permanent representative · Frédéric Clais
  • Officer appointment: role: bestuurder · AstraZeneca N.V.
  • Permanent representative · Anne-Laure Dreno
  • Officer reappointment: role: bestuurder · Bristol-Myers Squibb Belgium N.V.
  • Officer reappointment: role: bestuurder · GlaxoSmithKline Pharmaceuticals N.V.
  • Officer reappointment: role: bestuurder · Janssen-Cilag N.V.
  • Permanent representative · Sonja Willems
  • Officer reappointment: role: bestuurder · Novartis Pharma N.V.
  • Officer reappointment: role: bestuurder · Sanofi Belgium N.V.
  • Officer reappointment: role: bestuurder · Merck N.V.
  • Officer resignation: role: bestuurder · Celgene BVBA
  • Statute amendment · Algemene Vereniging van de Geneesmiddelenindustrie
  • Purpose: Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder. · Algemene Vereniging van de Geneesmiddelenindustrie
Summary: Act object · Board meeting · General meeting · Officer resignation
22-07-2020 Act object · Board meeting · Officer resignation · Officer appointment Open-capture extraction
  • Act object: Nomination Vice-Président Conseil d'administration et désignation représentants permanents des administrateurs · Association Générale de l'Industrie du Médicament
  • Publication: 22/07/2020 · Association Générale de l'Industrie du Médicament
  • Filing: 13/07/2020 · Association Générale de l'Industrie du Médicament
  • Board meeting: 19/02/2020 · Association Générale de l'Industrie du Médicament
  • Officer resignation: role: Directeur général, end_date: 2020-07-01 · Catherine Auguste J. Rutten
  • Officer appointment: role: Directeur général ad interim, start_date: 2020-07-01 · Ann Maria Marcel Ludo Adriaensen
  • Board meeting: 24/06/2020 · Association Générale de l'Industrie du Médicament
  • Officer appointment: role: Président du Conseil d'administration · Pfizer
  • Permanent representative · Karel Van De Sompel
  • Officer appointment: role: Vice-Président du Conseil d'administration · Eli Lilly Benelux
  • Permanent representative · Frédéric Clais
  • General meeting: 13/05/2020 · Association Générale de l'Industrie du Médicament
  • Officer appointment: role: administrateur · AstraZeneca S.A.
  • Permanent representative · Anne-Laure Dreno
  • Officer reappointment: role: administrateur · Bristol-Myers Squibb Belgium S.A.
  • Officer reappointment: role: administrateur · GlaxoSmithKline Pharmaceuticals S.A.
  • Officer reappointment: role: administrateur · Janssen-Cilag S.A.
  • Permanent representative · Sonja Willems
  • Officer reappointment: role: administrateur · Novartis Pharma S.A.
  • Officer reappointment: role: administrateur · Sanofi Belgium S.A.
  • Officer reappointment: role: administrateur · Merck S.A.
  • Officer resignation: role: administrateur · Celgene SPRL
  • Statute amendment · Association Générale de l'Industrie du Médicament
  • Purpose: Le but poursuivi par l'Association consiste en la représentation et la défense des intérêts moraux et matériels de l'industrie du médicament en général et de l'industrie des médicaments innovants en particulier. Parmi les activités concrètes menées par l'Association en vue de la réalisation de son but, on trouve notamment: a)un soutien scientifique, administratif, juridique et organisationnel aux membres... b)l'organisation de toutes activités visant à favoriser une meilleure compréhension des problèmes... c)la promotion... d'une efficiente collaboration entre les membres; d)le développement de toutes activités... contribuant directement ou indirectement à la réalisation du but désintéressé susmentionné... · Association Générale de l'Industrie du Médicament
Summary: Act object · Board meeting · Officer resignation · Officer appointment
2019
16-05-2019 Spasena Ivanova Yotova appointed as director Director changes
  • Spasena Ivanova Yotova, Bestuurder
Summary: v3.2
2018
31-12-2018 1 director appointed, 1 resigning Director changes
  • Christos Andriopoulos, Gedelegeerd bestuurder
  • Ariane Misonne, Gedelegeerd bestuurder
Summary: v3.2
31-12-2018 Christos Andriopoulos appointed as director Director changes
  • Christos Andriopoulos, Bestuurder
Summary: v3.2
31-12-2018 Ariane Misonne resigns as director Director changes
  • Ariane Misonne, Bestuurder
Summary: v3.2
First 20 of 33 acts

Analysis

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primary activity highlighted.
Names & trade names
Legal nameNL MERCK
Registered office
Ildefonse Vandammestraat 5/7B
1560 Hoeilaart, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.